Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
BACKGROUND: BCG, the only licensed tuberculosis vaccine, affords poor protection against lung tuberculosis in infants and children. A new tuberculosis vaccine, which may enhance the BCG-induced immune response, is urgently needed. We assessed the safety of and characterized the T cell response induc...
Autors principals: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2011
|